Biobanking in radiotherapy trials — a challenge to the clinical research community

Duncan C. Gilbert* (Corresponding Author), Valerie Speirs* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Precision oncology is predicated on information derived from high-quality tissue samples. Despite almost half of all patients with cancer receiving radiotherapy, samples from these patients are much less commonly available for use in biomarker studies. Biobanks that include material from radiotherapy studies do exist; the challenge is increasing their visibility and accessibility to researchers to continue our efforts to improve outcomes for our patients.
Original languageEnglish
Pages (from-to)191–192
Number of pages3
JournalNature Reviews Clinical Oncology
Early online date17 Feb 2021
Publication statusPublished - 1 Apr 2021

Bibliographical note

The authors wish to thank N. Curtin for initiating and contributing to this work, T. Ward (patient representative) and G. Higginbotham for their input, and the National Cancer Research Institute (NCRI) Clinical and Translational Radiotherapy Research Working Group (CTRad) and Cellular Molecular Pathology Initiative (CMPath) for making this work possible.


  • Oncology
  • radiotherapy


Dive into the research topics of 'Biobanking in radiotherapy trials — a challenge to the clinical research community'. Together they form a unique fingerprint.

Cite this